Schedule 13G ownership disclosure

REIN THERAPEUTICS INC

Security class unavailable · CUSIP: 00887A204

Event date: 2023-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
539,293
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-117321
Form type
SC 13G
Filer
Rein Therapeutics, Inc.
CIK
CIK 1420565
Filed
Nov 13, 2023
Reporting period
Oct 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub